Mantle Cell Lymphoma (MCL) Unknown Status Phase 2 Trials for Dexamethasone (DB01234)

Also known as: Mantle Cell Lymphomas / Lymphoma, Mantle-Cell / Mantle-Cell Lymphoma / Lymphoma, Mantle Cell / Mantle Cell Lymphoma / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS

IndicationStatusPhase
DBCOND0071979 (Mantle Cell Lymphoma (MCL))Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00261612Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell LymphomaTreatment